• About Us
  • Advertise
  • Contact Us
  • DMCA
  • Follow on Google News
Saturday, July 19, 2025
  • Login
News Mirror
  • Home
  • India
    • National
    • State News
  • World
  • Business
  • Education
  • Entertainment
  • Lifestyle
    • Health & Fitness
    • Fashion & Beauty
    • Travel
    • Food
    • Photography
  • Finance/Money
  • Tech
    • App News
    • Gadgets
  • Auto
  • Others
    • Sports
    • Agriculture
    • Science
    • Astrology
    • Press Release
    • Religion
    • Social Work
No Result
View All Result
  • Home
  • India
    • National
    • State News
  • World
  • Business
  • Education
  • Entertainment
  • Lifestyle
    • Health & Fitness
    • Fashion & Beauty
    • Travel
    • Food
    • Photography
  • Finance/Money
  • Tech
    • App News
    • Gadgets
  • Auto
  • Others
    • Sports
    • Agriculture
    • Science
    • Astrology
    • Press Release
    • Religion
    • Social Work
No Result
View All Result
News Mirror
No Result
View All Result
Home Lifestyle Health & Fitness

First mRNA-based COVID 19 vaccine gets nod for phase II/III trial

News Mirror by News Mirror
August 25, 2021
in Health & Fitness, National
Share on FacebookShare on Twitter

New Delhi: The fight against the ongoing epidemic of COVID-19 is all set to get stronger. The office of the Drug Controller General of India has approved a proposal of the Pune-based Gennova Biopharmaceuticals Ltd., to go in for phase II / III trial of the country’s first mRNA-based vaccine for COVID-19 called HGCO19.

The company had submitted the interim clinical data of the Phase I study to the Central Drugs Standard Control Organisation (CDSCO), the Government of India’s National Regulatory Authority (NRA). The Vaccine Subject Expert Committee (SEC) reviewed the data and found that the vaccine was safe, tolerable, and immunogenic in the participants of the study.

RelatedPosts

India’s First Clean Supplement Brand to Put a Traffic Light on ‘Healthy’ Food

VRA Health Bridges Healthcare Gaps: From COVID Crisis to Global Telemedicine Success

Consequently, the proposal for Phase II and Phase III study for “A prospective, multicentre, randomized, active-controlled, observer-blind, phase II study seamlessly followed by a phase III study to evaluate the safety, tolerability, and immunogenicity of the candidate HGCO19 (covid-19 vaccine) in healthy subjects” was submitted that has now been approved.

The study will be conducted within India in 10-15 sites in Phase II and 22-27 sites in Phase III. Gennova plans to use the DBT-ICMR clinical trial network sites for this study.

The vaccine development program was partly funded by the Department of Biotechnology (DBT), Govt. of India under Ind CEPI, in June 2020. Later on, the DBT further supported the program under the Mission COVID Suraksha – The Indian COVID-19 Vaccine Development Mission, implemented by BIRAC.

“It is a matter of great pride that Nation’s first mRNA-based vaccine is found to be safe and the Drugs Controller General of India DCG(I) has approved Phase II/III trial. We are confident that this will be an important vaccine for both India and the world. This is an important milestone in our Indigenous Vaccine Development Mission and positions India on the Global Map for Novel Vaccine Development,” said Dr.RenuSwarup, Secretary, DBT, and Chairperson, Biotechnology Industry Research Assistance Council (BIRAC).

Dr. Sanjay Singh, CEO of Gennova Biopharmaceuticals Ltd., said that “After establishing the safety of our mRNA-based COVID-19 vaccine candidate HGCO19 in Phase I clinical trial, Gennova’s focus is to start Phase II/III pivotal clinical trial. In parallel, Gennova is investing in scaling up its manufacturing capacity to cater to the nation’s vaccine requirement”. (India Science Wire)

Tags: CDSCOCentral Drugs Standard Control OrganisationCOVID SurakshaDBTDCG (I)Department of BiotechnologyDrug Controller General of IndiaGennova Biopharmaceuticals Ltd.immunogenicityInd CEPImRNAPunesafetytolerabilityvaccine
Previous Post

Ogo Nirupama actress Arkoja Acharyya celebrates Rakshabandhan with renowned singer and producer Sarbajit Ghosh through upcoming calendar photoshoot

Next Post

Government incentive in offing for 75 start-ups in telemedicine, artificial intelligence, and digital health

Related Posts

India’s First Clean Supplement Brand to Put a Traffic Light on ‘Healthy’ Food
Health & Fitness

India’s First Clean Supplement Brand to Put a Traffic Light on ‘Healthy’ Food

July 18, 2025
VRA Health Bridges Healthcare Gaps: From COVID Crisis to Global Telemedicine Success
Health & Fitness

VRA Health Bridges Healthcare Gaps: From COVID Crisis to Global Telemedicine Success

July 7, 2025
ClinicSpots Simplifies Online Doctor Consultation in India, Connecting Patients to Trusted Healthcare Experts Across Specialties
Health & Fitness

ClinicSpots Simplifies Online Doctor Consultation in India, Connecting Patients to Trusted Healthcare Experts Across Specialties

July 1, 2025
Revolutionizing Orthodontics with India’s First CAD/CAM-Based Lingual Bracket System
Health & Fitness

Revolutionizing Orthodontics with India’s First CAD/CAM-Based Lingual Bracket System

June 28, 2025
Giloy for the Monsoon: PravekKalp Offers a Natural Shield Against Infections
Health & Fitness

Giloy for the Monsoon: PravekKalp Offers a Natural Shield Against Infections

June 19, 2025
Aveya IVF & Fertility Center: Pioneering Accessible Parenthood with Fertility Solutions
Health & Fitness

Aveya IVF & Fertility Center: Pioneering Accessible Parenthood with Fertility Solutions

May 14, 2025
Next Post

Government incentive in offing for 75 start-ups in telemedicine, artificial intelligence, and digital health

Niti Vakharia Kharwar from Nits saloon was honoured by One Step Charitable Trust as “Real Heroes of Surat”

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended.

Dr Harsh Vardhan unveils posters to address vaccine hesitancy and misinformation

January 21, 2021

Coastal India to witness unprecedented job loss due to heat stress

January 14, 2021

Trending.

DHN Unveils Landmark Annual Digital Health Trends & Outlook 2025 Report at its Delhi Forum; AI Emerges as Top Priority

DHN Unveils Landmark Annual Digital Health Trends & Outlook 2025 Report at its Delhi Forum; AI Emerges as Top Priority

June 20, 2025
Raj Mishra Launches DigitechHorizons.com to Redefine Digital IP Protection for Creators and Innovators

Raj Mishra Launches DigitechHorizons.com to Redefine Digital IP Protection for Creators and Innovators

July 2, 2025
Global Innovator Radhakrishnan Arikrishna Perumal Sets a New Benchmark in Ethical AI and Insurance Technology

Global Innovator Radhakrishnan Arikrishna Perumal Sets a New Benchmark in Ethical AI and Insurance Technology

June 27, 2025
Shaligram Infotech Celebrates 10 Years of Driving Digital Innovation for Global Businesses

Shaligram Infotech Celebrates 10 Years of Driving Digital Innovation for Global Businesses

July 12, 2025
Global Health Awards 2025 Honours Excellence at the House of Lords

Global Health Awards 2025 Honours Excellence at the House of Lords

July 14, 2025
News Mirror

© 2022 News Mirror

  • About Us
  • Advertise
  • Contact Us
  • DMCA
  • Follow on Google News

Follow Us

No Result
View All Result
  • About Us
  • Advertise
  • Contact Us
  • DMCA
  • Home
  • Privacy Policy

© 2022 News Mirror

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In